Radiosensitization of Human Vascular Endothelial Cells Through Hsp90 Inhibition With 17-N-Allilamino-17-Demethoxygeldanamycin

International Journal of Radiation Oncology Biology Physics

Volumn 71, Issue 3, 2008, Pages 858-865

  Kabakov, Alexander E ^a   Makarova, Yulia M ^a   Malyutina, Yana V ^a  

^a MEDICAL RADIOLOGICAL RESEARCH CENTER   (Russian Federation)

Author keywords

Akt; Chaperone; Radiotherapy; Tumor vasculature

Indexed keywords

PHOSPHORYLATION; PROTEINS; RADIOTHERAPY; TUMORS;

ANTICANCER RADIOTHERAPY; DRUG INHIBITING; TUMOR VASCULATURE;

ENDOTHELIAL CELLS;

17 N ALLILAMINO 17 DEMETHOXYGELDANAMYCIN; 2 MORPHOLINO 8 PHENYLCHROMONE; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90 INHIBITOR; LIPOCORTIN 5; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ARTICLE; CELL CULTURE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; GAMMA IRRADIATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MORPHOGENESIS; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RADIATION DOSE; RADIOSENSITIZATION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

BENZOQUINONES; CELLS, CULTURED; ENDOTHELIAL CELLS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; LACTAMS, MACROCYCLIC; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS;

EID: 44449168998     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.02.034     Document Type: Article

References (35)

1. Garcia-Barros M., Paris F., Cordon-Cardo C., et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300 (2003) 1155-1159
2. Paris F., Fukz Z., Kang A., et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 293 (2001) 293-297
3. Kim D.W., Huamani J., Fu A., et al. Molecular strategies targeting the host component of cancer to enhance tumor response to radiation therapy. Int J Radiat Oncol Biol Phys 64 (2006) 38-46
4. Patterson D.M., and Rustin G.J. Vascular damaging agents. Clin Oncol (R Coll Radiol) 19 (2007) 443-456
5. Kabakov A. Heat shock proteins against radiation-induced apoptosis: Facts, hypotheses, prospects. In: Corvin A. (Ed). New developments in cell apoptosis research (2007), Nova Science Publishers, NY 121-158
6. Edwards E., Geng L., Tan J., et al. Phosphatidylinositol 3-kinase/Akt signaling in the response of vascular endothelium to ionizing radiation. Cancer Res 62 (2002) 4671-4677
7. Tan J., and Hallahan D.E. Growth factor-independent activation of protein kinase B contributes to the inherent resistance of vascular endothelium to radiation-induced apoptotic response. Cancer Res 63 (2003) 7663-7667
8. Zingg D., Riesterer O., Fabbro D., et al. Differential activation of the phosphatidylinositol 3′-kinase/Akt survival pathway in ionizing radiation in tumor and primary endothelial cells. Cancer Res 64 (2004) 5398-5406
9. Gupta V.K., Jaskowiak N.T., Beckett M.A., et al. Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance. Cancer J 8 (2002) 47-54
10. Kumar P., Miller A.I., and Polverini P.J. p38 MAPK mediates γ-irradiation-induced endothelial cell apoptosis, and vascular endothelial growth factor protects endothelial cells through the phosphoinositide 3-kinase-Akt-Bcl-2 pathway. J Biol Chem 279 (2004) 43352-43360
11. Brieger J., Schroeder P., Gosepath J., et al. VEGF-subtype specific protection of SCC and HUVECs from radiation induced cell death. Int J Mol Med 15 (2005) 145-151
12. Fuks Z., Persaud R.S., Alfieri A., et al. Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Res 54 (1994) 2582-2590
13. Pena L.A., Fuks Z., and Kolesnik R.N. Radiation-induced apoptosis of endothelial cells in the murine central nervous system: Protection by fibroblast growth factor and sphingomyelinase deficiency. Cancer Res 60 (2000) 321-327
14. Gu Q., Wang D., Wang X., et al. Basic fibroblast growth factor inhibits radiation-induced apoptosis of HUVECs. I. The PI3K/Akt pathway and induction of phosphorylation of BAD. Radiat Res 161 (2004) 692-702
15. Adams J., and Elliot P.J. New agents in cancer clinical trials. Oncogene 19 (2000) 6687-6692
16. Neckers L. HSP90 inhibitors as novel cancer chemotherapeutic agents. Trends Mol Med 8 (2002) 55-61
17. Chiosis G., Rodina A., and Moulick K. Emerging Hsp90 inhibitors: From discovery to clinic. Anticancer Agents Med Chem 6 (2006) 1-8
18. Enmon R., Yang W.H., Ballangrud A.M., et al. Combination treatment with 17-N-allylamino-17-demethoxy geldanamycin and acute irradiation produces supra-additive growth suppression in human prostate carcinoma spheroids. Cancer Res 63 (2003) 8393-8399
19. Bisht K.S., Bradbury C.M., Mattson D., et al. Geldanamycin and 17-allylamino-17-demethoxygeldanamycin potentiate the in vitro and in vivo radiation response of cervical tumor cells via the heat shock protein 90-mediated intracellular signaling and cytotoxicity. Cancer Res 63 (2003) 8984-8995
20. Russel J.S., Burgan W., Oswald K.A., et al. Enhanced cell killing induced by the combination of radiation and the heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin: A multitarget approach to radiosensitization. Clin Cancer Res 9 (2003) 3749-3755
21. Machida H., Nakajima S., Shikano N., et al. Heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin potentiates the radiation response of tumor cells growth as monolayer cultures and spheroids by inducing apoptosis. Cancer Sci 96 (2005) 911-917
22. Kobayashi S., Nantz R., Kitamura T., et al. Combined inhibition of extracellular signal-regulated kinases and HSP90 sensitizes human colon carcinoma cells to ionizing radiation. Oncogene 24 (2005) 3011-3019
23. Ochel H.J., and Gademann G. In vitro combined modality treatment of prostate carcinoma cells with 17-(allylamino)-17-demethoxygeldanamycin and ionizing radiation. Anticancer Res 26 (2006) 2085-2091
24. Shintani S., Zhang T., Aslam A., et al. P53-dependent radiosensitizing effect of Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin on human oral squamous cell carcinoma cell lines. Int J Oncol 29 (2006) 1111-1117
25. Camphausen K., and Tofilon P.J. Inhibition of Hsp90: A multitarget approach to radiosensitization. Clin Cancer Res 13 (2007) 4326-4330
26. Bull E.E., Dote H., Brady K.J., et al. Enhanced tumor cell radiosensitivity and abrogation of G2 and S phase arrest by the Hsp90 inhibitor 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin. Clin Cancer Res 10 (2004) 8077-8084
27. Kabakov A.E., Budagova K.R., Malyutina Y.V., et al. Pharmacological attenuation of apoptosis in reoxygenated endothelial cells. Cell Mol Life Sci 61 (2004) 3076-3086
28. Kabakov A.E., Malyutina Y.V., and Latchman D.S. Hsf1-mediated stress response can transiently enhance cellular radioresistance. Radiat Res 165 (2006) 410-423
29. 3 antagonist cilengitide enhances efficacy of radiotherapy in endothelial cells and non-small lung cancer models. Int J Radiat Oncol Biol Phys 65 (2006) 1536-1543
30. Michels A.A., Nguyen V.T., Konings A.W., et al. Thermostability of nuclear-targeted luciferase expressed in mammalian cells. Destabilizing influence of the intranuclear environment. Eur J Biochem 234 (1995) 382-389
31. Kampinga H.H., Kanon B., Salomons F.A., et al. Overexpression of the cochaperone CHIP enhances Hsp70-dependent folding activity in mammalian cells. Mol Cell Biol 23 (2003) 4948-4958
32. Kaur G., Belotti D., Burger A.M., et al. Antiangiogenic properties of 17-dimethylaminoethylamino-17-demethoxygeldanamycin: An orally bioavailable heat shock protein 90 modulator. Clin Cancer Res 10 (2004) 4813-4821
33. Sanderson S., Valenti M., Gowan S., et al. Benzoquinone ansamycin heat shock protein 90 inhibitors modulate multiple functions required for tumor angiogenesis. Mol Cancer Ther 5 (2006) 522-532
34. Tan J., Geng L., Yazlovitskaya E.M., et al. Protein kinase B/Akt-dependent phosphorylation of glycogen synthase kinase-3β in irradiated vascular endothelium. Cancer Res 66 (2006) 2320-2327
35. Kamal A., Thao L., Sensintaffar J., et al. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature 425 (2003) 407-410